Published in

American Association for Cancer Research, Clinical Cancer Research, 9(25), p. 2679-2681, 2019

DOI: 10.1158/1078-0432.ccr-19-0061

Links

Tools

Export citation

Search in Google Scholar

New Hope in Prostate Cancer Precision Medicine? miRNA Replacement and Epigenetics

Journal article published in 2019 by Anders Bjartell
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

AbstractSPINK1 +/ETS− prostate cancer is an aggressive disease with poor clinical outcome. New data suggest a novel treatment by upregulating the expression of miR-338-5p/-421 through epigenetic modulation or by miRNA replacement. This is a new and interesting concept that warrants further exploration in clinical trials.See related article by Bhatia et al., p. 2755